Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
ASSETS
Cash and cash equivalents	$ 21,656	$ 11,773
Restricted cash	6,421	1,010
Accounts receivable	7,656	2,494
Note Receivable	2,270	0
Due from related parties	3,615	2,667
Investment in unconsolidated subsidiaries	1,977	2,158
Prepaid expense and other assets	3,355	3,368
Property and equipment, net	1,000	1,124
Right-of-use assets	7,095	6,491
Deferred tax assets, net	35,494	37,621
Intangibles, net	136,306	143,738
Goodwill	417,401	369,982
Total assets	644,246	582,426
LIABILITIES:
Accounts payable	1,260	1,103
Accrued expenses	12,040	12,505
Due to related parties	1,650	2,200
Other liabilities	6,419	254
Contingent consideration	19,160	0
Deferred revenues	11,802	10,347
Lease liabilities	8,126	7,682
Debt obligations	315,517	290,055
Total liabilities	375,974	324,146
COMMITMENTS AND CONTINGENCIES (NOTE 12)
REDEEMABLE NONCONTROLLING INTEREST	199,202	198,439
STOCKHOLDERS' EQUITY:
Common stock - $0.001 par value; 110,000,000 and 110,000,000 shares authorized, respectively; 62,587,823 and 62,587,823 issued, respectively; 62,464,371 and 62,464,371 outstanding, respectively	63	63
Treasury stock	(273)	(273)
Additional paid-in-capital	325,762	324,310
Accumulated deficit	(256,482)	(264,259)
Total stockholders' equity	69,070	59,841
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 644,246	$ 582,426